Clinical Indication

Attention deficit hyperactivity disorder (ADHD)- prescribe CR formulation by brand name only


For information about products please see relevant Shared Care.
Adults:  Full SCA
Children & adolescents:  Full SCA

Date of classification

January 2009


Shared Care Agreement. Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.